Pratt S L, Anthony R V
Department of Animal Sciences, University of Missouri, Columbia 65211, USA.
Endocrinology. 1995 May;136(5):2150-5. doi: 10.1210/endo.136.5.7720664.
Specific binding of ovine GH (oGH) to microsomal membranes isolated from fetal sheep liver is slight to nonexistent. The complementary DNA sequence encoding the oGH receptor (oGHR) has been reported, and Northern blot analysis has indicated that oGHR messenger RNA (mRNA) is present in fetal liver and skeletal muscle from mid- to late gestation. In human tissues, the GHR mRNA exists in multiple forms, including the deletion of exon 3 and variable 5'-untranslated regions. In rodents, the GHR mRNA exists in two forms, one encoding the membrane-bound receptor and the other encoding the soluble GH-binding protein. To further characterize the oGHR mRNA transcript present in ovine fetal liver during gestation, we designed a series of primers to be used in reverse transcriptase-polymerase chain reactions (RT-PCR), which generate products that span from the 5'-untranslated region through the coding region of the oGHR mRNA. Nucleotide sequences of the resulting complementary DNAs revealed that an oGHR mRNA is present from mid- to late gestation (days 60-135) which contains the region analogous to exon 3 of the human GHR gene. However, the 5'-untranslated region previously reported in adult tissues was not present until day 135 of gestation in fetal liver, nor was it present in day 100 fetal skeletal muscle. Northern hybridization analysis indicates that the major oGHR transcript in day 105 fetal liver is 5.8 kilobases (kb) in size, with minor transcripts observed at 4.7 kb and three transcripts greater than 6.5 kb. By day 135 of gestation, the transcript size is the same as that observed in day 100 pregnant ewe liver (5.5 kb). We conclude that the oGHR mRNA present in midgestation fetal liver differs structurally from the transcript present in late gestation fetal liver and adult liver, and this difference may explain the lack of specific GH binding to ovine fetal liver membranes. Furthermore, our results suggest that there is a developmental switch in the structure of oGHR mRNA that occurs shortly before term, potentially preparing the fetus to respond to GH postnatally.
绵羊生长激素(oGH)与从胎羊肝脏分离的微粒体膜的特异性结合很微弱甚至不存在。编码oGH受体(oGHR)的互补DNA序列已被报道,Northern印迹分析表明oGHR信使核糖核酸(mRNA)存在于妊娠中期至晚期的胎肝和骨骼肌中。在人体组织中,GHR mRNA存在多种形式,包括外显子3缺失和可变的5'-非翻译区。在啮齿动物中,GHR mRNA存在两种形式,一种编码膜结合受体,另一种编码可溶性GH结合蛋白。为了进一步表征妊娠期间胎羊肝脏中存在的oGHR mRNA转录本,我们设计了一系列引物用于逆转录聚合酶链反应(RT-PCR),该反应产生的产物跨越oGHR mRNA从5'-非翻译区到编码区。所得互补DNA的核苷酸序列显示,妊娠中期至晚期(第60 - 135天)存在一种oGHR mRNA,其包含与人GHR基因外显子3类似的区域。然而,先前在成年组织中报道的5'-非翻译区直到妊娠第135天才出现在胎肝中,在妊娠第100天的胎骨骼肌中也不存在。Northern杂交分析表明,妊娠第105天胎肝中的主要oGHR转录本大小为5.8千碱基(kb),在4.7 kb处观察到次要转录本,还有三个大于6.5 kb的转录本。到妊娠第135天,转录本大小与妊娠第100天怀孕母羊肝脏中观察到的相同(5.5 kb)。我们得出结论,妊娠中期胎肝中存在的oGHR mRNA在结构上与妊娠晚期胎肝和成年肝脏中存在的转录本不同,这种差异可能解释了GH与胎羊肝细胞膜缺乏特异性结合的原因。此外,我们的结果表明,oGHR mRNA的结构在足月前不久发生了发育转变,这可能使胎儿在出生后能够对GH作出反应。